Paul Rickey
2018
In 2018, Paul Rickey earned a total compensation of $751.3K as Senior Vice President and Chief Financial Officer at Nivalis Therapeutics, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $86,500 |
|---|---|
| Option Awards | $329,764 |
| Salary | $335,000 |
| Total | $751,264 |
Rickey received $335K in salary, accounting for 45% of the total pay in 2018.
Rickey also received $86.5K in non-equity incentive plan and $329.8K in option awards.
Rankings
In 2018, Paul Rickey's compensation ranked 10,436th out of 14,244 executives tracked by ExecPay. In other words, Rickey earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,436 out of 14,244 | 27th |
Division Manufacturing | 4,207 out of 5,765 | 27th |
Major group Chemicals And Allied Products | 1,582 out of 2,128 | 26th |
Industry group Drugs | 1,336 out of 1,817 | 27th |
Industry Pharmaceutical Preparations | 1,027 out of 1,391 | 26th |
Source: SEC filing on May 5, 2020.
Rickey's colleagues
We found three more compensation records of executives who worked with Paul Rickey at Nivalis Therapeutics in 2018.